Insights

DISCOVER

COMPANY

Survey

SURVEY

Consulting

COUNSULTING

Create New Account

Book discovery call

Flow Cytometry Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21326

Download Sample Report

Published On

July 2021

Total pages

129 Table of Content

Market Overview
Scope Of The Report
Product covered
Table Of Content
Research Methodology
FAQs

Download Sample Report

About the Report

Flow cytometry is a technique used in the study of cell particles and molecules to provide information about certain characteristics of specific cells. Flow cytometry research is used to analyze the cells of cancer and the immune system to describe the hematological malignancies. Also, this technique is a vital component in the evaluation of primary immune deficiency disorder. This has increased the adoption of cytometric techniques in the research field. For instance, in April 2021, Thermo Fisher Scientific Inc. has donated to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval of the first CAR T cell immunotherapy for multiple myeloma developed by Bristol Myers Squibb and bluebird bio. Abecma is a chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of certain adult patients with relapsed or refractory multiple myeloma, a blood cancer formed by malignant plasma cells and typically originating in the bone marrow.

Moreover, certain factors that will hinder the growth of this market involve the availability of alternate and cheaper instruments, high costs associated with flow cytometry reagents and techniques, budget limitations for research purposes, expensive installation, and maintenance costs. Further, the scarcity of skilled laborers and technicians in labs and diagnostic centers will also hinder the growth of the flow cytometry market in the forecast period.

During the COVID-19 pandemic, the flow cytometry market has experienced healthy growth. The increasing acceptance of research activities and clinical trials due to the Covid-19 have functioned as a driving factor for the uses of flow cytometry techniques. For instance, in late July 2020, based on promising results from early-stage clinical testing of the mRNA-1273 vaccine moved to Phase 3 clinical testing. The trial is intended to evaluate the safety of mRNA-1273 and to determine if the vaccine can prevent symptomatic COVID-19 after two doses. Also, the trial aims to study whether the vaccine can prevent severe COVID-19 or laboratory-confirmed SARS-CoV-2 infection with or without disease symptoms. This trial also seeks to answer if the vaccine can prevent death caused by COVID-19 and whether just one dose can prevent symptomatic COVID-19, among other objectives. Thus, the research and clinical trials related to the Covid-19 vaccination have surged the growth of flow cytometry during the forecast period.

Based on product, the market is bifurcated into instruments, reagents & consumables, replaceable components, accessories, software, and services. The reagents & consumables segment grabbed the major market in 2020 due to their augmented implementations in diagnostic and research fields. Moreover, the overview of multiplex probes and reagents for precise applications in diagnostics as well as drug discovery is anticipated to increase the growth opportunities of this segment in research laboratories and small peripheral laboratories.

Based on technology, the market is bifurcated into cell-based and bead-based technologies. The bead-based segment ruled the major market and accounted for the maximum share in 2020 due to the practical advantages presented by this technology over the cell-based technology (such as ELISA, northern blot, and western blot), comprising its ability to spot multiple analytes, high reproducibility, stability, and speed.

Based on application, the market is bifurcated into research applications, clinical applications, and industrial applications. The research applications segment grabbed the major market in 2020 and accounted for the maximum revenue during the forecast period. The highest share of this segment is attributed due to the increasing R&D activities connected to cancer and infectious diseases, including COVID-19. Further, the increasing R&D investments in the pharmaceutical and biotechnology companies are also anticipated to generate a favorable atmosphere for this market growth.

Based on end-user, the market is bifurcated into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. The hospitals & clinical testing laboratories segment ruled the major market and accounted for the maximum share in 2020 due to the increasing number of research for chronic diseases like cancer, HIV AIDS, Immunological disorders including COVID-19. Moreover, an upsurge in organ transplantation practices will also help this market growth over the forecast period.

For a better understanding of the market adoption of the e-Pharmacy market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for flow cytometry and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled workforces.

Scope of the Report

Products

Flow cytometry is a technique used in the study of cell particles and molecules to provide information about certain characteristics of specific cells.

Companies

Thermo Fisher Scientific, Beckman Coulter, Inc., Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Apogee Flow Systems Ltd., and Sony Biotechnology, Inc.

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Flow Cytometry Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Flow Cytometry Market

2.1.1 Main Objective of the Global Flow Cytometry Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER FLOW CYTOMETRY INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL FLOW CYTOMETRY MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

8.1 Instruments

8.2 Reagents and Consumables

8.3 Replaceable components

8.4 Accessories

8.5 Software

8.6 Services

9 MARKET INSIGHTS BY TECHNOLOGY

9.1 Cell-based

9.2 Bead-based

10 MARKET INSIGHTS BY APPLICATION

10.1 Research Applications

10.2 Clinical Applications

10.3 Industrial Applications

11 MARKET INSIGHTS BY END-USER

11.1 Academic & Research Institutes

11.2 Hospitals & Clinical Testing Laboratories

11.3 Pharmaceutical & Biotechnology Companies

12 MARKET INSIGHTS BY REGION

12.1 NORTH AMERICA FLOW CYTOMETRY MARKET

12.1.1 United States

12.1.2 Canada

12.1.3 Rest of North America

12.2 EUROPE FLOW CYTOMETRY MARKET

12.2.1 Germany

12.2.2 France

12.2.3 United Kingdom

12.2.4 Spain

12.2.5 Italy

12.2.6 Rest of Europe

12.3 ASIA PACIFIC FLOW CYTOMETRY MARKET

12.3.1 China

12.3.2 Japan

12.3.3 India

12.3.4 Australia

12.3.5 South Korea

12.3.6 Rest of Asia Pacific

12.4 REST OF THE WORLD FLOW CYTOMETRY MARKET

13 FLOW CYTOMETRY MARKET DYNAMICS

13.1 Market Drivers

13.2 Market Challenges

13.3 Impact Analysis

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

15.1 Demand Side Analysis

15.2 Supply Side Analysis

15.2.1 Top Product Launches

15.2.2 Top Business Partnerships

15.2.3 Top Merger & Acquisitions

16 VALUE CHAIN ANALYSIS

17 FLOW CYTOMETRY MARKET OPPORTUNITIES

18 FLOW CYTOMETRY MARKET TRENDS & INSIGHTS

19 COMPETITIVE SCENARIO

19.1 Porter's Five forces analysis

19.1.1 Bargaining power of Supplier

19.1.2 Bargaining power of Buyer

19.1.3 Industry Rivalry

19.1.4 Availability of Substitute

19.1.5 Threat of new Entrants

20 COMPANY PROFILED

20.1 Thermo Fisher Scientific

20.1.1 Key Facts

20.1.2 Business Description

20.1.3 Key Product/Services Offerings

20.1.4 Growth Strategy

20.1.5 SWOT Analysis

20.1.6 Key Financials

20.1.6.1 Revenue Split

20.1.6.2 Financial Overview of Thermo Fisher Scientific

20.1.7 Recent Developments

20.1.7.1 Product Launch

20.1.7.2 Partnerships

20.1.7.3 Business Expansion and Investments

20.1.7.4 Merger and Acquisition

20.2 Beckman Coulter, Inc.

20.3 Danaher Corporation

20.4 Becton, Dickinson, and Company

20.5 Luminex Corporation

20.6 Agilent Technologies, Inc.

20.7 Bio-Rad Laboratories, Inc.

20.8 Miltenyi Biotec

20.9 Apogee Flow Systems Ltd.

20.10 Sony Biotechnology, Inc.

21 DISCLAIMER

Research Methodology

Why Buy From Us?

Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository

150+ Consulting project a year

100+ Analysts

8000+ Client Queries in 2022